Entero Healthcare Solutions Limited has announced the outcome of its Board Meeting held on November 4, 2026. The company approved its unaudited financial results for the quarter and half year ended September 30, 2026, along with the limited review reports. Additionally, the Board noted the grant of 49,712 employee stock options under the existing “Entero Employee Stock Option Plan 2023.” The trading window will open 48 hours after this disclosure.
Entero Healthcare Board Meeting Outcomes
Entero Healthcare Solutions Limited convened its Board Meeting on November 4, 2026, to discuss and approve key financial and operational matters. The Board considered and approved the unaudited financial results (standalone and consolidated) for the quarter and half year that concluded on September 30, 2026. These results were accompanied by the Limited Review Reports issued by the company’s statutory auditors, which expressed an unmodified opinion.
Employee Stock Option Grant Approved
Further to the approval of the Nomination & Remuneration Committee, the Board also noted the grant of 49,712 (Forty-Nine Thousand Seven Hundred Twelve) employee stock options. These options have been granted under the company’s existing “Entero Employee Stock Option Plan 2023.” The details of these options, as required by SEBI regulations, are provided in Annexure-B.
Trading Window Update
In line with the company’s Code of Fair Disclosure of Unpublished Price Sensitive Information, the trading window for dealing in the securities of Entero Healthcare Solutions Limited will open after the expiry of 48 hours from the disclosure of these financial results. This information was previously communicated via letter dated September 23, 2026.
Financial Highlights (Standalone)
For the quarter ended September 30, 2026, Entero Healthcare reported a profit before exceptional items and tax of ₹243.19 million. Total tax expenses amounted to ₹51.75 million, leading to a profit for the period of ₹191.44 million. Total comprehensive income stood at ₹194.21 million. Earnings per share (basic and diluted) were ₹4.40 and ₹4.39, respectively.
For the half year ended September 30, 2026, profit before exceptional items and tax was ₹289.24 million. Total tax expenses were ₹63.23 million, resulting in a profit for the period of ₹226.01 million. Total comprehensive income was ₹228.08 million. Earnings per share (basic and diluted) were ₹5.19 and ₹5.18, respectively.
Financial Highlights (Consolidated)
On a consolidated basis, for the quarter ended September 30, 2026, profit before exceptional items and tax was ₹783.87 million. Total tax expenses were ₹176.45 million, leading to a profit for the period of ₹607.42 million. Total comprehensive income was ₹628.03 million. Earnings per share (basic and diluted) were ₹10.47 and ₹10.45, respectively.
For the half year ended September 30, 2026, profit before exceptional items and tax reached ₹1,455.07 million. Total tax expenses were ₹327.14 million, resulting in a profit for the period of ₹1,127.93 million. Total comprehensive income stood at ₹1,147.24 million. Earnings per share (basic and diluted) were ₹19.24 and ₹19.20, respectively.
Source: BSE
